Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

• Haoning Guo,
• Bin Wang,
• Shuying Yuan,
• Silin Wu,
• Jing Liu,
• Miaoquan He,
• Jisheng Wang

Affiliations

Haoning Guo

Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

Bin Wang

Clinical Experimental Center, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China

Shuying Yuan

Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

Silin Wu

Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

Jing Liu

Department of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

Miaoquan He

Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

Jisheng Wang

Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China